Affiliation:
1. Division of Epidemiology and Community Health School of Public Health University of Minnesota Minneapolis MN
2. Division of Geriatrics Department of Medicine University of Mississippi Medical Center Jackson MS
3. Division of Hematology and Oncology Department of Medicine University of Vermont Colchester VT
4. Division of Epidemiology College of Public Health University of Kentucky Lexington KY
5. Department of Epidemiology Gillings School of Public Health University of North Carolina, Chapel Hill NC
6. Division of Biostatistics School of Public Health University of Minnesota Minneapolis MN
Abstract
Background
Relatively little is known about the long‐term consequences of venous thromboembolism (VTE) on physical functioning. We compared long‐term frailty status, physical function, and quality of life among survivors of VTE with survivors of coronary heart disease (CHD) and stroke, and with those without these diseases.
Methods and Results
Cases of VTE, CHD, and stroke were continuously identified since ARIC (Atherosclerosis Risk in Communities Study) recruitment during 1987 to 1989. Functional measures were objectively captured at ARIC clinic visits 5 (2011–2013) and 6 (2016–2017); quality of life was self‐reported. The 6161 participants at visit 5 were, on average, 75.7 (range, 66–90) years of age. By visit 5, 3.2% had had a VTE, 6.9% CHD, and 3.4% stroke. Compared with those without any of these conditions, VTE survivors were more likely to be frail (odds ratio [OR], 3.11; 95% CI, 1.80–5.36) and have low (<10) versus good scores on the Short Physical Performance Battery (OR, 3.59; 95% CI, 2.36–5.47). They also had slower gait speed, less endurance, and lower physical quality of life. VTE survivors were similar to coronary heart disease and stroke survivors on categorical frailty and outcomes on Short Physical Performance Battery assessment. When score on the Short Physical Performance Battery instrument was modeled continuously, VTE survivors performed better than stroke survivors but worse than CHD survivors.
Conclusions
VTE survivors had triple the odds of frailty and poorer physical function than those without the vascular diseases considered. Their function was somewhat worse than that of CHD survivors, but better than stroke survivors. These findings suggest that VTE patients may benefit from additional efforts to improve postevent physical functioning.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cardiology and Cardiovascular Medicine
Reference48 articles.
1. Lifetime risk of venous thromboembolism in two cohort studies;Bell EJ;Am J Med,2016
2. Heart disease and stroke statistics 2019 update: a report from the American Heart Association;Benjamin EJ;Circulation,2019
3. Incidence of and mortality from venous thromboembolism in a real‐world population: the Q‐VTE Study Cohort;Tagalakis V;Am J Med,2013
4. Anticoagulant preferences and concerns among venous thromboembolism patients;Lutsey PL;Thromb Haemost,2018
5. Rivaroxaban versus standard anticoagulation for symptomatic venous thromboembolism (REMOTEV observational study): Analysis of 6-month outcomes
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献